Hill Dermaceuticals Rewrites The Lab Books, So FDA Throws The Book At The Firm
This article was originally published in The Pink Sheet Daily
Executive Summary
A district court issued a consent decree against Hill, its president and quality assurance manager; government alleges the company repeatedly failed to correct violations cited by FDA since 2004.